What is MDCX's dilution risk score?

MDCX has a latest available DilutionScore record of 71/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for MDCX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for MDCX?

DilutionWatch tracks 25 SEC filing types for MDCX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MDCX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MDCX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MDCX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MDCX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MDCX Dilution Risk Score: 71/100 (HIGH)

Score Breakdown

📋 Offering Ability

85

💰 Cash Runway

65

📊 Float Risk

20

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 50%

🔄 Reverse Split model est. 65%

• 50-day avg $0.36 below $1 exchange minimum

• 8 months cash with weak price

💰 Capital Raise model 53%

• Under 12 months cash (8mo)

• Active shelf registration ($8M, 37% of market cap)

📉 Score Deterioration model 10%

• Score in HIGH risk zone (71/100)

🔔 Track MDCX — Get forecast alerts →

Market Data

Market Cap$21.47M

Shares Outstanding63.18M

Float50.14M

Cash$15.17M

Debt$2.34M

Short InterestN/A

Institutional Holdings

10 institutional holders · 3.93M shares

#1 Armistice Capital, LLC 1.81M shares

#2 Interchange Capital Partners, LLC 1.66M shares

#3 Private Advisor Group, LLC 175.5K shares

+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.01M

Days to Cover1.8

% of Float6.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2025-12-31

424B3 ATM 2026-08-13

4 INSIDER TRANSACTION 2026-06-04

Full SEC filing analysis available with free account →

Recent News

Medicus Pharma cleared by FDA for registrational Phase 2b trial in patients with Proactive · Jul 27

Medicus Pharma receives FDA clearance to begin registrational SkinJect study for Yahoo Finance · Jul 27

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registra Yahoo Finance · Jul 27

Factual MDCX Dilution Snapshot

Medicus Pharma Ltd. (MDCX) has a DilutionScore of 71/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $8.0M.
Stored ATM program remaining capacity: $50.0M.
Recent SEC activity tracked for MDCX: 424B3 on 2026-08-13; 4 on 2026-06-04; 4 on 2026-06-04.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.